Redondo Beach, California Clinical Trials

A listing of Redondo Beach, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 37 clinical trials
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

This study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma. The breast cancer in this study is either metastatic (spread into other parts of the body) …

Torrance Memorial Physician Network - TRIO
 (3.4 away) Contact site
  • 0 views
  • 14 Mar, 2022
  • +227 other locations
Treatment of Moderate to Severe Lateral Canthal Lines

The objective of the study is to evaluate the efficacy and safety of a single dose of QM1114-DP compared to placebo for the treatment of moderate to severe LCL.

Ablon Skin Institute and Research Center
 (2.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression

The main objectives of this trial are to evaluate the efficacy and safety of oral BI 1358894 compared to placebo over a 6-week treatment period in participants with Major Depressive Disorder (MDD) and with inadequate response to antidepressants (SSRI or SNRI) utilizing a decentralized clinical trial (DCT) model.

suicide
serotonin and norepinephrine reuptake inhibitors
depression
serotonin reuptake inhibitors
antidepressants
Science 37, Inc.
 (8.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

body mass index
tirzepatide
cardiovascular disease
dulaglutide
Harbor UCLA Medical Center
 (5.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +650 other locations
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168 (PERSEUS)

Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple sclerosis (PPMS) Secondary Objectives: To evaluate efficacy of SAR442168 compared to placebo on clinical endpoints, magnetic resonance imaging (MRI) lesions, cognitive performance, physical function, and quality of life To evaluate safety …

oligoclonal bands
multiple sclerosis
Investigational Site Number 8400088
 (5.7 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +14 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

pleural effusion
refractory non-hodgkin lymphoma
MRI
growth factor
platelet transfusion
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
 (5.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +82 other locations
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults Adolescents and Pediatrics

The purpose of this study is to demonstrate the performance of the Disposable Sensor (DS5) in subjects age 2 - 80 years, for the span of 170 hours (7 days).

type 1 diabetes mellitus
insulin
continuous glucose monitoring
type 2 diabetes mellitus
insulin sensitivity
SoCal Diabetes
 (3.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +12 other locations